Search - tctmd.com

Displaying 61 - 80 of 688

Sort: Relevancy | Date

Presentation TCT 2024

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

Presenter: Patrick Serruys

October 27, 2024

Presentation TCT 2024

TCT 1385: Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty to Treat Ostial Circumflex In-Stent Restenosis

Presenter: Fernando Cohen

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

Podcast TCTMD Talking Points

The AGENT IDE Trial

June 05, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Daily News

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Todd Neale

May 03, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Daily News

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

Shelley Wood

February 19, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Cage-free CTO PCI: Recanalization of three CTOs with drug coated balloon angioplasty

Presenter: Dinesh Selvakumar

February 02, 2024

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

Advertisement

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

TCT 1385: Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty to Treat Ostial Circumflex In-Stent Restenosis

What’s Going to Be Big at TCT 2024?

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

The AGENT IDE Trial

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

Cage-free CTO PCI: Recanalization of three CTOs with drug coated balloon angioplasty

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content